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Adherence to Recommendations for
Follow-up to Abnormal Pap Tests
Katherine S. Eggleston, MSPH, Ann L. Coker, PhD, Kathryn J. Luchok, PhD, and Tamra E. Meyer, MPH
OBJECTIVE: To evaluate whether timely adherence rates
differ by race among women with abnormal Pap tests
participating in a cost-free or reduced-cost program.
METHODS: Eligible subjects included women aged
47–64 years who received a referral for follow-up care
after an abnormal Pap test from 1999 to 2002 in South
Carolina (n330). Adherence was measured as days to
receipt of follow-up care after an abnormal Pap test. Cox
proportional hazards modeling was used to estimate risk
factors associated with time to adherence within 60 and
365 days by race.
RESULTS: African-American and non-Hispanic white
women had similar adherence to follow-up. Among
white women, those with high-grade lesions were less
likely to adhere in a timely manner relative to those with
low-grade lesions (hazard ratio 0.6, 95% confidence
interval [CI] 0.4–1.0). For African-American women, rural
residence (hazard ratio: 0.5, 95% CI 0.2–0.9) and history
of abnormal Pap tests (hazard ratio 0.6, 95% CI 0.3–1.0)
were associated with decreased adherence, whereas less
education (hazard ratio 2.3, 95% CI 1.3–3.9) was associ-
ated with increased adherence.
CONCLUSION: Adherence rates do not differ by race.
However, risk factors for adherence within race are
variable. Interventions tailored to the differential needs
of racial and ethnic groups may prove effective toward
increasing timely adherence rates.
(Obstet Gynecol 2007;109:1332–41)
LEVEL OF EVIDENCE: II
Cervical cancer mortality rates range from 1.3 to6.1 deaths per 100,000 women across the United
States.1 Mortality resulting from cervical cancer can
be attributed to three main factors: lack of consistent
Pap testing,2–5 failure of the Pap test to detect an
abnormality,6,7 and lack of adherence to recom-
mended follow-up after an abnormal Pap test result.6,7
High rates of Pap test usage in the United States are
encouraging, but approximately 7% of Pap tests are
abnormal and require medical follow-up.8 Women
with less access to routine screening, including low-
income and minority women, are therefore at in-
creased risk of dying from this disease.
Although several studies have assessed barriers to
and predictors of cervical cancer screening, few have
focused on predictors of receiving follow-up care for
abnormal Pap test results. Among women who are
regularly screened, those with abnormal Pap tests
who are referred for follow-up care are those most at
risk for developing cervical cancer. Follow-up after an
abnormal Pap test has become increasingly expensive
and out of range for many low-income women with-
out insurance.9–12 Other factors shown to be associ-
ated with lack of adherence to follow-up recommen-
dations include age,10,12–17 race,10,13,14,16,18–22 severity of
Pap test result,10,11,13,15,16,18,20–24 knowledge,10,14,16,21,25–30
patient provider communication,9,17,24 social sup-
port,25 and psychological factors.14,26–29
African Americans have a higher incidence of
cervical cancer and have a higher cervical cancer
mortality rate than white women.31 This disparity may
be due to differences in follow-up rates after an
abnormal Pap test. Seven10,14,16,19–22 of 15 studies
10,13,14,16,17,19–24,27–29,32 to address race/ethnicity and ad-
herence found that African-American women were
less likely to schedule follow-up visits, to keep ap-
pointments, or to receive follow-up care. Because of
this mixed literature regarding race and adherence,
additional research is needed to determine if and why
African-American women with an abnormal Pap test
are less likely than non-Hispanic white women to
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adhere to physician recommendations for abnormal
Pap test follow-up.
The Centers for Disease Control and Preven-
tion’s National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) provide breast and
cervical cancer screening and follow-up care to unin-
sured, low-income women aged 47–64 years in the
United States.33 The NBCCEDP has an active pro-
gram in South Carolina, a southern state with high
percentages of minority and low-income residents. In
2005, the mortality rate due to cervical cancer in
South Carolina was 3.1 per 100,000 women, exceed-
ing the national average of 2.7 per 100,000 women.1
Although it ranks 26th in population size, South
Carolina ranks seventh in the nation for estimated
deaths from cervical cancer.1 African-American and
other nonwhite women were 60% more likely to be
diagnosed with cervical cancer than white women in
South Carolina.34
The Centers for Disease Control (CDC) funded
the current project for the purpose of investigating
why some women with abnormal Pap tests do not
adhere to recommendations for receipt of care in a
timely manner. The purpose of this analysis is to
evaluate whether timely adherence rates differ by
race among women with abnormal Pap tests. Differ-
ences in adherence rates may be due to lesion sever-
ity, socioeconomic status, rural residence, education,
smoking, marital status, and previous abnormal Pap
tests.
MATERIALS AND METHODS
Potential study participants were identified by the
South Carolina BCCEDP. The current study was
approved by institutional review boards at all partic-
ipating institutions. Eligible subjects included women
aged 47–64 years who received a referral for fol-
low-up care after an abnormal Pap test from 1999 to
2002 (n330).
The primary outcome for this analysis was adher-
ence to follow-up recommendations. Compliance is
defined by the BCCEDP as completion of follow-up
care within 60 days of the initial abnormal Pap test.22
The impact of the exposures relative to adherence to
follow-up recommendations may vary over time;
therefore, we created an additional measure of adher-
ence, defined as time to first follow-up within 365
days.
Participation in the current study included com-
pletion of a phone interview regarding a woman’s
abnormal Pap test experience. Detailed methodology
for this research study has been published else-
where.35 Concepts to be addressed in this analysis as
correlates of adherence include race, age, education,
marital status, socioeconomic status, rural residence,
smoking, previous abnormal Pap tests, and lesion
severity. Data from both medical records (demo-
graphics, lesion severity, and timely adherence to
follow-up) and the questionnaire (race, education,
marital status, smoking status, and previous abnormal
Pap tests) contributed to the current data analysis.
Thus, information obtained from medical records was
available for all women enrolled in the South Caro-
lina BCCEDP (n330), whereas information ob-
tained from the questionnaire was available only for
interviewed women (n149).
A composite variable for community level socio-
economic status was created using U.S. Census 2000
ZIP code level data for median income, poverty,
education, and employment.36 Community level so-
cioeconomic status is an important aspect of a wom-
an’s environment, reflecting various community re-
sources influencing access to care. Rural residence
was also defined using the ZIP code level data avail-
able from the U.S. Census. Socioeconomic status and
rural residence were then categorized into tertiles
based on the distribution of the data among all
women.
All data were analyzed with Intercooled Stata 8.0
(Stata Corporation, College Station, TX). Two models
were developed corresponding to the availability of
exposure variables for women who were interviewed
compared with those who did not complete the
interview. Model 1 consisted of variables obtained
from medical records, from the U.S. Census, or from
both. Exposure data for variables obtained from the
U.S. census were available for 99% (n326) of all
women in the primary data set (n330). Unavailabil-
ity corresponds to women with ZIP codes corre-
sponding to a post office box; data for these ZIP codes
are not reported in the U.S. Census. The second
model consisted of variables that were obtained
through participation in the questionnaire (education,
smoking status, marital status, previous abnormal Pap
tests) (n149). Cox proportional hazards modeling
was used to estimate relative hazard ratios for adher-
ence to follow-up recommendations for the two time
periods and for the two samples. The 2 and t test
were used to evaluate statistically significant differ-
ences between variables across the racial/ethnic
groups. Further, the 2 test for trend37 was used to test
linear trends across socioeconomic status and rural
residence. Women who did not adhere to follow-up
within 60 or 365 days were censored in respective
models.
Age and lesion severity were both assessed as
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confounders, but only lesion severity met the opera-
tional definition of confounding and was included in
the model as a confounder. Race was included as the
primary exposure to determine whether race was
associated with time to adherence at 60 and 365 days
in models including lesion severity, education, rural
residence, history of a past abnormal Pap, and smok-
ing. Finally, we explored whether risk factors for
adherence differed by race. The Breslow-Day test for
homogeneity38 was used to determine whether race
modified the association between identified risk fac-
tors associated with adherence.
RESULTS
Of 183 African-American women and 147 white
women identified by BCCEDP as referred for fol-
low-up care from 1999 to 2002 in South Carolina, 83
African Americans and 66 white women completed
phone interviews. Table 1 presents the demographic
characteristics of women by race and study sample.
The mean age of women in the full sample was
53.54.7 years. The majority (48.2%) of women were
diagnosed with a cervical lesion defined as atypical
squamous cells of undetermined significance
(ASCUS). Most women were nonsmokers (73.2%),
had at least a high school education (62.4%), and had
no previous abnormal Pap tests (54.7%). Approxi-
mately 47% of all women were married at the time of
the abnormal Pap test. The demographic profiles of
African-American and white women interviewed in
this study were similar, with the exception that more
white women were current smokers and were more
likely to have had a history of an abnormal Pap. No
differences were observed across the demographic
profile between women who participated in the inter-
view and the total sample.
Adherence status and time to adherence for all
women receiving care through the BCCEDP are
presented in Table 2 by race. Most women adhered to
follow-up recommendations within 60 days (62.8% of
African Americans and 69.4% of white Americans),
and almost all adhered within 365 days (95.9% of
African Americans and 95.6% of white Americans).
On average, African-American women received fol-
low-up care 7.6 days (3.9) later than white American
women, but this difference was not statistically signif-
icant and is unlikely to be of clinical significance.
Tables 3 and 4 present predictors of adherence to
follow-up recommendations within 60 and 365 days
after an abnormal Pap test. When adherence was
defined based on BCCEDP records, presence of a
higher- rather than a lower-grade lesion was associ-
ated with nonadherence at both 60 and 365 days after
an abnormal Pap test. Those women living in areas of
intermediate socioeconomic status were more likely
to receive follow-up care within 60 days than women
living in areas of higher socioeconomic status.
Women with less than a high school education were
also more likely to receive follow-up care in a timely
manner (within 60 days) than those with at least a high
school diploma.
Tables 5 and 6 present correlates of adherence at
60 and 365 days by race. No factor investigated was
consistently associated with both racial groups.
Among white women, lesion severity (high versus
low grade) was the only variable associated with
adherence within 60 days (hazard ratio 0.6, 95%
confidence interval [CI] 0.4–1.0) and 365 days (haz-
ard ratio 0.6, 95% CI 0.4–0.9). African-American
women living in very rural areas were less likely to
adhere to follow-up recommendations in a timely
manner (hazard ratio 0.5, 95% CI 0.2–0.9 for adher-
ence within 60 days) than those living in urban areas;
the trend of rural residence and adherence was also
significant (P.02). Additionally, those living in areas
of intermediate socioeconomic status compared with
those living in areas of high levels of socioeconomic
status were more likely to be adherent within 60 days.
However, no trend toward increasing socioeconomic
status being associated with greater adherence was
noted (P.21). African-American women with less
than a high school education were significantly more
likely to adhere to follow-up recommendations at
both 60 (hazard ratio 2.3, 95% CI 1.3–3.9) and 365
days (hazard ratio 2.0, 95% CI 1.2–3.3) than those
attaining at least a high school education. Finally,
although having a history of an abnormal Pap test was
associated with a reduced likelihood of adherence at
60 days (hazard ratio 0.6, 95% CI 0.3–1.0), this
association was not significant for follow-up at 365
days.
DISCUSSION
Timely adherence to treatment and follow-up care for
an abnormal Pap test greatly reduces the risk of
progression to invasive cervical cancer. Although
racial disparities exist for incidence of and mortality
due to cervical cancer, this study found no difference
between African-American and white women in days
to follow-up care or overall adherence status at 60 or
365 days after an abnormal Pap test. This finding is
consistent with some previous research13,17,23,24,27–29,32
that concluded that African-American race was not an
independent predictor of adherence to follow-up rec-
ommendations. However, this finding contrasts with
others10,13,14,16,18–22 who note that African-American
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women were less likely to schedule follow-up visits,
keep appointments, or receive follow-up care.
Several factors associated with adherence dispro-
portionately affected women in each racial group in-
cluding lesion severity, rural residence, education, and
history of abnormal Pap test. The majority of studies
report that women with more severe lesions are more
likely to adhere to follow-up recommendations than
those with less severe lesions.10,11,13,15,16,18,20–24 However,
results from this study indicate that, among white Amer-
icans, women with more severe lesions were less likely
to adhere to follow-up. This association remained re-
gardless of the time frame for adherence (60 or 365
days). Reasons for this association are not clear but may
involve fatalistic attitudes of being diagnosed with a
high-grade lesion, as well as competing life priorities
Table 1. Characteristics of Women Referred for Follow-up Care After Abnormal Pap Test in South
Carolina, 1999–2002










Age (y, meanSD) 53.74.7 53.14.7 53.65.0 53.44.9
P (t test)* .27 .80
Lesion type
ASCUS 91 (51.4) 65 (44.2) 40 (48.2) 31 (47.0)
LSIL/HPV 54 (27.9) 41 (27.9) 26 (31.3) 19 (28.8)
HSIL/AGUS/SCC 38 (20.7) 41 (27.9) 17 (20.5) 16 (24.2)
P (2)† .27 .85
Rural residence (n182) (n144) (n83) (n66)
Very rural 62 (34.1) 49 (34.1) 29 (35.0) 20 (30.3)
Rural 61 (33.5) 47 (33.5) 27 (32.5) 22 (33.3)
Urban 59 (32.4) 48 (32.4) 27 (32.5) 24 (36.4)
P (2)† .98 .82
Socioeconomic status (n182) (n144) (n83) (n66)
Low SES 58 (31.9) 30 (20.8) 27 (32.5) 15 (22.7)
Middle SES 60 (33.0) 55 (38.2) 29 (35.0) 28 (42.4)
High SES 64 (35.1) 59 (41.0) 27 (32.5) 23 (34.9)
P (2)† .08 .40
Education — — (n83) (n66)
High school diploma
or greater — — 52 (62.1) 41 (62.7)
Less than high school
diploma — — 31 (37.9) 25 (37.3)
P (2)† — .95
Marital status — — (n83) (n66)
Married — — 39 (47.0) 31 (47.0)
Divorced/separated — — 22 (26.5) 19 (28.8)
Single — — 6 (7.2) 1 (1.5)
Widowed — — 16 (19.3) 15 (22.7)
P (2)† — .42
Smoking status‡ — — (n83) (n66)
No — — 68 (81.9) 41 (62.1)
Yes — — 15 (18.1) 25 (37.9)
P (2)† — .01
Any other abnormal Pap
test — — (n76) (n61)
No — — 48 (63.2) 27 (44.3)
Yes — — 28 (36.8) 34 (55.7)
P (2)† — .03
SD, standard deviation; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion;
HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; AGUS, atypical glandular cells of undetermined
significance; SCC, squamous cell carcinoma; SES, socioeconomic status.
Data are expressed as n (%) except where otherwise indicated.
* t test P value tests racial difference across age.
† Chi-square P value tests racial differences across adherence status.
‡ Smoking status defined as being a smoker in year of abnormal Pap.
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such as work or child care. Two studies investigating
fatalism and adherence found that those with higher
fatalism scores were less likely to be adherent.26,29 Addi-
tional research is needed to better understand the influ-
ence of women’s psychosocial response to an abnormal
Pap test and their ability to cope effectively with this
news and receive needed care in a timely manner.
To address the possibility that white women with
high-grade lesions were treated by other health care
providers, we conducted a separate analysis among
interviewed women to address the association be-
tween lesion severity and self-reported adherence. It
was assumed that self-reported adherence included
both treatment received within the BCCEDP as well
as through other health care providers. The resulting
hazard ratio was not significant (hazard ratio 0.6, 95%
CI 0.3–1.1), but it indicated an effect of similar
direction and magnitude when compared with the
original results using adherence based solely on BC-
CEDP records (Table 5, hazard ratio 0.6, 95% CI
0.4–0.9). Therefore, we do not believe this difference
is due to treatment outside the BCCEDP.
Our finding of no association between socioeco-
nomic status trend and adherence is consistent with
the majority of studies reporting adherence was not
associated with higher income, insurance, or cost of
treatment.13,14,16,17,23,29,32,39 This contrasts with four
studies that found that women with higher income or
private insurance were more likely to adhere to
recommended treatment.9–12 Because the majority of
women in the current study were low income, we had
little variance in the socioeconomic status distribution
and potentially limited ability to detect a modest
effect of socioeconomic status on adherence.
In the only study to address residential status as a
predictor of adherence, Fox et al20 concluded that
women in urban settings of California were more
likely to receive follow-up care. This finding concurs
with our observation that, among African-American
women, those living in very rural areas are less likely
to receive follow-up care within 60 days of an abnor-
mal Pap result than were those living in urban areas.
Presumably, rural residence may affect adherence by
creating a barrier to care through either greater
distance to care or limited transportation. We note
that rural residence disproportionately affects adher-
ence for African-American women in need of fol-
low-up care.
Women with lower education levels may be less
likely to adhere to follow-up recommendations due in
part to ineffective communication between the pro-
vider and the patient. We do not have data from
providers on communication methods or follow-up
instructions. However, our current data shows no
differences across education levels in a woman’s recall
of either the notification or lesion severity of her Pap
test results.
Educational interventions, including counseling
to better explain to women their condition and need
for treatment, have been shown to increase compli-
ance among poorly educated patients.10,14,16,21,26–28,30
Our finding that women with less than a high school
education are more likely to adhere to follow-up
recommendations than are women with at least a high
Table 2. Adherence to Follow-up Recommendation After an Abnormal Pap Test by Race in South
Carolina, 1999–2002










Adhered in 60 days 115 (62.8) 102 (69.4) 54 (65.1) 48 (72.7)
P (2)* .21 .32
Adhered in 60 days:
self-report NE NE 52 (62.6) 47 (71.2)
P (2)* NE .27
Adhered in 365 days 141 (95.9) 175 (95.6) 64 (97.0) 78 (94.0)
P (2)* .90 .39
Mean days to follow-up
(meanSE) 74.96.1 67.36.5 77.710.1 65.99.7
P (t test)† .40 .41
NE, not estimable (subject not interviewed); SE, standard error.
Data are expressed as n (%) except where otherwise indicated.
* Chi square P value tests racial differences across indicated variable.
† t test P value tests racial difference across indicated variable.
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school diploma may reflect providers’ awareness of
the greater needs of less educated women to have the
consequences of an abnormal Pap test clearly and
carefully described in simple language. Health care
providers who are part of the BCCEDP program may
be particularly attuned to the needs of their less
educated patients; they may provide simple explana-
tions and facilitate referrals for women with less
education. A qualitative study of BCCEDP providers
in South Carolina, the majority of whom are not
physicians, showed that nurse practitioners and mid-
wives were more likely than physicians to recognize
cognition problems in their patients and to use non-
medical, simple communication, as well as visual
diagrams when discussing abnormal results.40
An alternative theory is that less educated women
may have a heightened anxiety for the possibility of
cervical cancer, whereas more educated women may
view an abnormal Pap as not at all worrisome.
However, our questionnaire included a question on
how concerned the woman was when she was con-
tacted about her abnormal Pap test. Responses were
not significantly different by education status, and
thus anxiety does not likely explain this finding.
Having a history of an abnormal Pap test was
associated with lower levels of adherence at 60 days in
this sample. An explanation for this observation may
be found in a qualitative study of BCCEDP clients
who reported that women who had repeated abnor-
mal Pap tests were frustrated to be called back
repeatedly for retesting and reported that “since noth-
ing had happened yet due to abnormal Pap tests, they
Table 3. Predictors of Adherence Within 60 and 365 Days After an Abnormal Pap Test in South


















African Americans 0.014 (115) 0.9 (0.7–1.1) 0.013 (175) 0.9 (0.7–1.1)
P .20 .32
White Americans 0.017 (102) 1.0 Ref 0.014 (141) 1.0 Ref
Lesion severity†
High-grade lesion 0.012 (44) 0.7 (0.5–1.0) 0.011 (75) 0.8 (0.6–1.0)
P .04 .06
Low-grade lesion 0.017 (173) 1.0 Ref 0.014 (241) 1.0 Ref
Rural residence‡
Very rural 0.013 (66) 0.7 (0.4–1.1) 0.013 (107) 0.9 (0.6–1.3)
P .16 .53
Rural 0.018 (75) 0.9 (0.6–1.4) 0.015 (104) 1.0 (0.8–1.5)
P .73 .80
Urban 0.016 (74) 1.0 Ref 0.013 (101) 1.0 Ref
P (2 for trend)§ .14 .48
Socioeconomic status
Low SES 0.013 (52) 1.1 (0.7–1.7) 0.012 (84) 1.0 (0.7–1.5)
P .81 .95
Middle SES 0.019 (84) 1.5 (1.0–2.2) 0.015 (111) 1.2 (0.9–1.7)
P .04 .21
High SES 0.015 (79) 1.0 Ref 0.013 (117) 1.0 Ref
P (2 for trend)¶ .80 .91
CI, confidence interval; Ref, reference; SES, socioeconomic status.
* Event rate  number adhered/person days.
† Low-grade lesion is defined as low-grade squamous intraepithelial lesion/human papillomavirus, atypical squamous cells of undetermined
significance; high-grade lesion is defined as atypical glandular cells of undetermined significance, high-grade squamous intraepithelial
lesion, carcinoma.
‡ Model includes adjustment for socioeconomic status.
§ Trend test evaluates association between increasing rural residence and adherence.
 Model includes adjustment for rural residence; composite socioeconomic status includes zip code level variables for median income,
poverty, education, and employment.
¶ Trend test evaluates association between increasing socioeconomic status and adherence.
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just quit returning.” (Luchok K, Modayil M, Abbott
JM, Brandt HM, Prabhu Das I, Coker AL. Congru-
ence between clinician and client perspectives on
factors affecting follow-up of abnormal Pap test re-
sults. Presented at: 132nd Annual Meeting of the
American Public Health Association, November
6–10, 2004; Washington, DC.)
This study is not without limitations. Response
rates for participation, while acceptable, were lower
than desired (67% for white and 60% for African-
American women). These response rates contributed
to small sample size and limited power to detect
modest differences within racial groupings. However,
because response rates did not differ significantly by
race and women did not know their adherence status
by time, this potential selection bias is unlikely to
explain study findings. Selection bias may play a role
in any study that includes voluntary participation. It is
likely that those who participated in our interview are
more motivated to address health issues than those
who do not, thus making them more likely to adhere
to treatment recommendations. However, we believe
this bias is unlikely due to similar adherence rates. We
reduced the potential for misclassification by using
both medical record and interview data to validate
both adherence status and race among interviewed
women. Unfortunately, we were not able to obtain
medical records of women who received care outside
BCCEDP practices, yet it appears few women opt to
pay for care when care is provided free within the
BCCEDP network.
Another limitation to this study is the use of
aggregate data (U.S. Census data) as indicators for
individual socioeconomic status and rural residence.
Defining rural residence by ZIP code is not likely to
result in significant misclassification because residen-
tial conditions do not vary greatly for individuals
within a ZIP code. This may not be the case for
ZIP-code-level socioeconomic status. Variances in
individual income, education, and employment are
likely to occur for individuals across ZIP codes,
resulting in potential misclassification of socioeco-
Table 4. Predictors of Adherence Within 60 and 365 Days After an Abnormal Pap Test in South


















African Americans 0.016 (54) 0.9 (0.6–1.3) 0.012 (78) 0.9 (0.6–1.2)
P .43 .37
White Americans 0.018 (48) 1.0 Ref 0.015 (64) 1.0 Ref
Education†
Less than high school
diploma 0.020 (43) 1.5 (1.0–2.2) 0.015 (53) 1.3 (0.9–1.9)
P .06 .12
High school diploma
or greater 0.015 (59) 1.0 Ref 0.012 (89) 1.0 Ref
Smoking status
Smoker 0.015 (27) 0.9 (0.6–1.4) 0.012 (38) 0.9 (0.6–1.3)
P .57 .66
Nonsmoker 0.017 (75) 1.0 Ref 0.014 (104) 1.0 Ref
Marital status
Unmarried 0.017 (55) 1.1 (0.7–1.6) 0.014 (76) 1.1 (0.8–1.5)
P .76 .74
Married 0.016 (47) 1.0 Ref 0.013 (66) 1.0 Ref
Previous abnormal Pap test
Yes 0.015 (41) 0.8 (0.6–1.3) 0.013 (59) 0.9 (0.7–1.3)
P .40 .70
No 0.018 (53) 1.0 Ref 0.013 (72) 1.0 Ref
CI, confidence interval; Ref, reference.
* Event rate  number adhered/person days.
† Model includes adjustment for lesion severity.
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nomic status. However, the constructed ZIP-code-
level socioeconomic status composite variable is a
reasonable proxy for individual socioeconomic status,
given that all women included in the sample are low
income and either uninsured or underinsured. An
effect of misclassification would be nondifferential
and would bias the resulting association between
socioeconomic status and adherence toward the null,
indicating that the true association would be stronger
than reported.
Adherence to treatment and follow-up care for an
abnormal Pap test greatly reduces the risk of progres-
sion to invasive cervical cancer. Although racial dis-
parities exist for incidence of and mortality due to
cervical cancer, this study found no racial differences
in adherence to follow-up care for an abnormal Pap
test. However, several factors associated with adher-
ence disproportionately affected women in each ra-
cial group. Interventions to address timely adherence
to follow-up care recommendations after an abnormal
Table 5. Predictors of Adherence in the Full Sample Within 60 and 365 Days After an Abnormal Pap
Test, by Race in South Carolina, 1999–2002
Full Sample (n330) Hazard Ratios (95% CI)
African American White American
Time to adherence (d) 60 365 60 365
Total person days 6,084 13,708 7,971 9,893
Lesion severity*
High versus low grade 0.8 (0.5–1.3) 1.0 (0.7–1.4) 0.6 (0.4–1.0) 0.6 (0.4–0.9)
P .31 .99 .03 .01
Rural residence†
Very rural versus urban 0.5 (0.2–0.9) 0.6 (0.4–1.1) 1.2 (0.6–2.4) 1.4 (0.7–2.5)
P .02 .09 .65 .34
Rural versus urban 0.7 (0.4–1.2) 0.8 (0.5–1.3) 1.2 (0.7–2.1) 1.3 (0.8–2.1)
P .22 .38 .45 .23
P (2 for trend)‡ .02 .08 .64 .31
Socioeconomic status§
Low versus high SES 1.6 (0.8–3.1) 1.3 (0.8–2.2) 0.7 (0.3–1.5) 0.7 (0.4–1.3)
P .19 .32 .35 .26
Middle versus high SES 2.0 (1.2–3.5) 1.5 (0.9–2.3) 1.0 (0.6–1.8) 1.0 (0.6–1.5)
P .01 .09 .94 .86
P (2 for trend) .21 .40 .37 .27
CI, confidence interval; SES, socioeconomic status.
* Low-grade lesion is defined as low-grade squamous intraepithelial lesion/human papillomavirus, atypical squamous cells of undetermined
significance; high-grade lesion is defined as atypical glandular cells of undetermined significance, high-grade squamous intraepithelial
lesion, carcinoma.
† Model includes adjustment for socioeconomic status.
‡ Trend test evaluates association between increasing rural residence and adherence.
§ Model includes adjustment for rural residence; composite socioeconomic status including zip code level variables for median income,
poverty, education, and employment.
Table 6. Predictors of Adherence in the Interviewed Sample Within 60 and 365 Days After an Abnormal
Pap Test, by Race in South Carolina, 1999–2002
Interviewed Sample (n149) Hazard Ratios (95% CI)
African American White American
Time to adherence (d) 60 365 60 365
Person days 3,450 6,451 2,664 3,450
Education*
Less than high school diploma versus high school
diploma or greater 2.3 (1.3–3.9) 2.0 (1.2–3.3) 0.8 (0.5–1.5) 0.7 (0.4–1.2)
P .01 .01 .50 .24
Previous abnormal Pap test
Yes versus no 0.6 (0.3–1.0) 0.7 (0.5–1.2) 1.3 (0.7–2.3) 1.3 (0.8–2.1)
P .06 .21 .42 .38
CI, confidence interval.
* Model includes adjustment for lesion severity.
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Pap test may be most effective if they are culturally
competent and tailored to the differential needs of
racial and ethnic groups.
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